Macon, Ga.-based Central Piedmont Investment Group’s funding will support field testing of Reservoir Spoke technology in metro Atlanta.
The UGA research efforts of Ted Ross, Georgia Research Alliance Eminent Scholar of Infectious Diseases and director of the Center for Vaccines and Immunology, have led to more than a dozen invention disclosures, several pending patent applications, and three license agreements.
UGA startup ArunA Biomedical launched a new class of cell-free exosome biologics to treat central nervous system and neurodegenerative disorders.
Innovation Gateway occasionally receives requests from companies seeking solutions to product development challenges and expressing interest in new research tools that may be used in research relating to human, veterinary and plant diseases (broadly defined).
The University of Georgia was well represented at the Georgia Bio Awards, with five awards recognizing programs either at or affiliated with the university.
Industry Express makes negotiating research agreements a faster and more transparent process that also eliminates uncertainty about licensing costs.
Athens-based UGA startup IS3D, maker of Cogent Education™ interactive educational software, was acquired by Cambium Learning® Group. IS3D was founded by eight UGA faculty and staff members including Tom Robertson, Ph.D., a former associate professor in the College of Veterinary … Continued
The second of four events in Innovation Gateway’s annual Technology Transfer Educational Series, Bridging the Gap Between Academia and Industry, was held in November. The third event will be held Thursday, February 8, 1 to 2 p.m., in Coverdell Auditorium S175.
Hitesh Handa, an assistant professor in the UGA College of Engineering, has developed a surface coating with an antimicrobial function that attacks harmful bacteria by releasing nitric oxide, a naturally occurring gas with potent antimicrobial properties.
UGA I-Corps is accepting applications for its second cohort to begin in January 2018.
Sometimes perfecting an existing technique can open the doors to new possibilities.
Associate professor Brian Schwartz and professor Wayne Hanna are UGA turfgrass breeders at the Tifton campus.
Three new cold-tolerant citrus cultivars developed by Wayne Hanna, a professor in the department of crop and soil sciences in the College of Agricultural and Environmental Sciences, have been exclusively licensed to a South Georgia nursery, 1 DOG Ventures, LLC. These include the first citrus cultivars released by UGA.
Innovation Gateway has released its third Technology Catalog, which lists device-type technologies aimed at applications in the agricultural, medical and telecommunication sectors.
Ralph Tripp is a professor of infectious diseases, a Georgia Research Alliance Eminent Scholar and Chair of Animal Health Vaccine Development, and a recipient of the UGA Entrepreneur of the Year Award.
Three University of Georgia units have been named finalists in a competition recognizing innovative programs that develop economic prosperity locally and beyond.
Innovation Gateway commercialization and entrepreneurial activity saw big increases in FY 17.
Innovation Gateway executed exclusive license agreements for two new wheat cultivars developed by Mohamed Mergoum and Jerry Johnson, department of crop and soil sciences.
Jason Locklin is an associate professor in the department of chemistry and College of Engineering and Director of the New Materials Institute, a transdisciplinary and collaborative effort to research and develop new processes, products, and materials based on green engineering principles.
Ruth Davis and Ruihua Dong, research professionals with the Monoclonal Antibody Facility at UGA’s Bioexpression and Fermentation Facility, won this year’s poster competition at the annual meeting of the Southeastern Association of Shared Resources (SEASR) in June in Tampa, Fla.
Innovation Gateway is committed to growing the UGA innovation ecosystem and expanding the impact of products and companies emerging from UGA research, both here in Georgia and around the world.
Lynkogen, a UGA biotech startup developing therapies for diabetes based on the research of Dexi Liu, College of Pharmacy, received a $25,000 Phase IB GRA Ventures award from the Georgia Research Alliance.
Biao He is the Georgia Research Alliance Distinguished Investigator and the Fred C. Davison Distinguished University Chair in Veterinary Medicine at UGA.
For the third consecutive year, the University of Georgia was ranked among the top 100 universities worldwide for the number of U.S. patents granted in 2016, according to a list released this week by the National Academy of Inventors and the Intellectual Property Owners Association.
Innovation Gateway has released its 2017 Research Tools Catalog, which includes hundreds of technologies available for licensing, as well as related services UGA provides in support of researchers and companies.
The lab of Mary Ann Moran, department of marine sciences, was highlighted in the “Featured Lab” section of Kerafast’s newsletter.
Mark Eiteman, recipient of the UGA Inventor of the Year Award in 2014 and Professor of BioChemical Engineering and Microbiology in the College of Engineering, is the inventor of multiple metabolic engineering technologies directed toward industrial-scale production of commodity and specialty chemicals with the concomitant consumption of CO2.
The University of Georgia has been named an Innovation Corps Site by the National Science Foundation, enhancing UGA’s ability to turn ideas and research discoveries into commercially viable products or services by providing early evaluation of projects through a customer discovery process.
UGA Regents’ Professor Michael R. Strand has been elected to the National Academy of Sciences, one of the highest honors a scientist can receive.
Dexi Liu, the Panoz Professor of Pharmacy and head of the department of pharmaceutical and biomedical sciences, College of Pharmacy, is co-founder of Lynkogen, Inc., a pre-clinical stage biotechnology startup company developing protein-based pharmaceutics for the treatment of obesity, fatty liver, and other metabolic diseases.